Pembrolizumab (pembro) + chemotherapy (chemo) as neoadjuvant treatment for triple negative breast cancer (TNBC): preliminary results from KEYNOTE‑173 - Schmid, P; Park, Y H; Muñoz-Couselo, E (J Clin Oncol, 2017)
(Suppl.): Abstr. 556